RMB I struggle with the idea that Thero messed up a good buyout offer Thero an accountant -so I guess he got his head around any numbers... he also stood to gain an immense amount personally on a BO When the SP was 25 was anyone going to offer 30 -40 plus ? With patent litigation live ? And at that time no EU approval I favour more that no one came in ... Now Amarin can be bought on the cheap - 15 - but will anyone come in whilst USA market going downwards unless Marjac / infringement win ? Cutting costs in USA is right - Thero thought USA market could grow despite generics ... that is what he was out on and a clear out now shows KM does not run with the idea that 500 reps (those leaving) could make any difference - so let’s cut the costs in USA No debt / big tax loss / 500m cash and now a smaller head count all clear the decks better as to Possible BO interest But in any event makes good business sense - Alm